(Q36379139)

13 August 2017

1 reference

title

Risks of pregnancy in women with epilepsy (English)

1 reference

13 August 2017

1 reference

Yerby MS

1

1 reference

13 August 2017

publication date

1 January 1992

1 reference

13 August 2017

1 reference

13 August 2017

volume

33 Suppl 1

1 reference

13 August 2017

page(s)

S23-6; discussion S26-7

1 reference

Precursor prothrombin status in patients receiving anticonvulsant drugs

13 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1157.1992.TB05897.X

The fetal valproate syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1157.1992.TB05897.X

The fetal hydantoin syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1157.1992.TB05897.X

Neonatal coagulation defect due to anticonvulsant drug treatment in pregnancy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1157.1992.TB05897.X

Maternal valproic acid and congenital neural tube defects

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1157.1992.TB05897.X

A possible primidone embryopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1157.1992.TB05897.X

Modulation of phenytoin teratogenicity and embryonic covalent binding by acetylsalicylic acid, caffeic acid, and alpha-phenyl-N-t-butylnitrone: implications for bioactivation by prostaglandin synthetase

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1157.1992.TB05897.X

10.1111/J.1528-1157.1992.TB05897.X

21 January 2018

Identifiers

DOI

1 reference

13 August 2017

1 reference